Pain signalling in humans more rapid than previously known

Pain signals can travel as fast as touch signals, according to a new study led by researchers from Linköping University. The discovery of a rapid pain-signalling system challenges our current understanding of pain. The...

Neuronal transport factor detects its target transcripts in more complex manner than previously thought

A team of scientists from Helmholtz Zentrum München and the University of Ulm has discovered that the neuronal transport factor Staufen2 scans and binds to its target transcripts in a much more complex manner...

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS) found that deactivating a specific protein - interleukin 11 (IL11) - with drugs called therapeutic antibodies, reverses inflammation and...

An itch to scratch: NCATS, NIDCR scientists identify potential approach to chronic problem

Credit: Hans Juergen Solinski, National Institute of Dental and Craniofacial Research Chronic itch goes beyond being just a simple annoyance; it can greatly affect a person’s quality...

Career Tips This Week: Good Night, and Sleep Tight 🤤

Hello biotechies,As the 2020 United States presidential campaign heats up, The New York Times reached out 21 Democratic candidates and asked them how many hours of sleep do they normally get a night. Most...

4 Technologies Improving Food Safety

Food safety is an increasingly prevalent concern for consumers. So many individuals are conscious of the food they’re consuming, where it was grown, whether pesticides or growth hormones were used, and so on. Regardless...

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M

The UK-based biotech Silence Therapeutics has signed a deal worth up to €553M ($693M) with the UK pharma company Mallinckrodt to develop RNA interference (RNAi) therapies for autoimmune diseases. Mallinckrodt will pay Silence Therapeutics €17.8M...

Stem cell scientists clear another hurdle in creating transplant arteries

Cardiovascular disease is a major cause of death worldwide, and treating it isn’t easy.  The disease wreaks havoc on patients’ blood vessels and can require complex bypass surgery. Scientists at the Morgridge Institute for Research...

Scientific breakthrough provides new hope for people living with multiple sclerosis

A scientific breakthrough provides new hope for millions of people living with multiple sclerosis. Researchers at Oregon Health & Science University have developed a compound that stimulates repair of the protective sheath that covers...

How Vaccines Could One Day Beat HIV

Vaccines are humanity’s biggest achievement against infectious diseases. But could they defeat HIV, a particularly crafty virus? José Luis Cabero, CEO of Spanish biotech AELIX Therapeutics shared his experience developing an HIV vaccine at...

Stay connected

43,497FollowersFollow
13,900SubscribersSubscribe

Recent posts

Random article